Motif Bio PLC Exercise of Warrants (9759M)
15 Maggio 2020 - 8:00AM
UK Regulatory
TIDMMTFB
RNS Number : 9759M
Motif Bio PLC
15 May 2020
Motif Bio plc
("Motif Bio" or the "Company")
Exercise of Warrants
Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM
Rule 15 cash shell, announces that it has received notification
from a warrant holder to exercise warrants representing 7,142,857
ordinary shares of 0.01p each ("Ordinary Shares") in the Company
for total consideration of GBP48,571.43. The exercise price of all
warrants was 0.68p per warrant.
Application has been made for the 7,142,857 new Ordinary Shares
to be admitted to trading on AIM ("Admission"), which is expected
to occur at 8.00 a.m. on 20 May 2020. The new Ordinary Shares will
rank pari passu with the existing Ordinary Shares. The Company does
not hold any Ordinary Shares in treasury.
Following Admission, and further to the announcement made on 5
May 2020, and for the purposes of the Disclosure Guidance and
Transparency Rules, the Company's total issued share capital will
consist of 654,991,023 Ordinary Shares. Shareholders may use this
figure as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the issued share capital of the
Company.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
For further information please contact:
ir@motifbio.com
Motif Bio plc
Jonathan Gold (President and Chief
Business Officer)
SP Angel Corporate Finance LLP (NOMAD
& BROKER) +44 (0)20 3470 0470
David Hignell/Caroline Rowe (Corporate
Finance)
Vadim Alexandre/Abigail Wayne (Sales
& Broking)
Walbrook PR Ltd. (UK FINANCIAL PR
& IR) +44 (0)20 7933 8780
Paul McManus/ Lianne Cawthorne motifbio@walbrookpr.com
Forward-Looking Statements
When used in this Press Release, the words or phrases "intends,"
"anticipates," "expected to be" or similar expressions are intended
to identify "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
are subject to certain risks and uncertainties including, but not
limited to, changes in economic conditions in the Company's market
area, changes in policies by regulatory agencies, fluctuations in
interest rates, competition that could cause actual results to
differ materially from historical earnings and those presently
anticipated or projected, and other risks described in the
Company's filings with the Securities and Exchange Commission. The
Company cautions readers not to place undue reliance on any such
forward-looking statements, which speak only as of the date made.
The Company advises readers that the factors listed above could
affect the Company's financial performance and could cause the
Company's actual results for future periods to differ materially
from any opinions or statements expressed with respect to future
periods in any current statements. The Company does not undertake,
and specifically disclaims any obligation, to publicly release the
result of any revision which may be made to any forward-looking
statements to reflect events or circumstances after the date of
such statements or to reflect the occurrence of anticipated or
unanticipated events.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOESFEFMLESSEFI
(END) Dow Jones Newswires
May 15, 2020 02:00 ET (06:00 GMT)
Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Lug 2023 a Lug 2024